Typhoid

Efficacy of Levofloxacin Versus Ciprofloxacin in the Treatment of Childhood Typhoid Fever

Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blantyre, Malawi

Typhoid Conjugate Vaccine Trial Among Children Younger Than 2 Years in Ouagadougou, Burkina Faso

Transcriptomic Responses for the Identification of Pathogens

ZyVac-TCV Bangladesh Study

Non-inferiority Trial of Locally Manufactured Typhoid Conjugate Vaccine 'Typhocon' in Bangladesh

Effects of Aging on Primary and Secondary Vaccine Responses

Immunogenicity, Safety and Tolerability of the Typhoid Fever Vaccine Candidate M01ZH09 in Healthy Adults

Co-administration Study of OCV, TCV and MR

Understanding Typhoid Disease After Vaccination

Immune Equivalence Between Multi-dose and Single Dose Formulation of Vi-DT and Their Overall Safety (Phase III)

Safety, Reactogenicity and Immunogenicity of Vi-DT;Typhoid Conjugate Vaccine

Safety and Immunogenicity of a Vi-DT Typhoid Conjugate Vaccine

Immune Non-inferiority and Safety of a Vi-DT Typhoid Conjugate Vaccine

A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults

Studies of Immune Responses to Orally Administered Vaccines in Developing Country

Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever

Combined Vi Vaccination and Health Education Program on the Burden of Typhoid in Childhood

Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, China

Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central Vietnam